Aristotle University Of Thessaloniki (AUTH)
Προέλευση του γονιδίου της αιμοσφαιρίνης S (HbS) στην Παλαιστίνη
Abstract
dc:descriptionSickle cell anaemia (SS) is an inherited chronic hemolytic disease due to a single point mutation substituting thymine for adenine at codon 6 of the β–globin gene. The high prevalence of the βˢ mutation in Africa, the Middle East, India and in parts of the Mediterranean has a relation to the selective protective effect of sickle cell hemoglobin (HbS) against malaria. Its spread to other regions of the world may be due to slave trade and/or population migration. The aim of the present study was; 1) To determine the origin of βˢ mutation among Palestinian patients with sickle cell disease. 2) To study the effect of haplotype on the haematological characteristics of sickle cell disease. 3) To further explore the causes of the variability in Hb F levels in sickle cell disease. 4) To explore how frequent and diverse are recombinations in chromosomes carrying the βˢ gene associated with common (or typical) haplotypes. 5) To study the genetic flow of sickle cell disease haplotypes among normal Palestinians (βᴬ chromosomes). 6) To assess the influence of thrombophilic mutations (factor V Leiden (G1691A) and Prothrombin (G20210A)) on the hypergoagability and thrombosis of sickle cell disease. Patients comprised 117 individuals with SCD, of whom 59 were SS (30 males and 29 females) aged 16 ± 9.9 years, 25 were AS (14 males and 11 females) aged 21.2 ± 9.1 years, and 33 were S/β thalassemia (18 males and 15 females) aged 15.1 ± 5.1 years. The control group was 78 apparently healthy individuals (57 males and 21 females) aged 20.6 ± 5.5 years. All patients came from different Palestinian cities and were all followed at the National Center for Blood Diseases “HIPPOCRATES”, Rammallah, Palestine. The β-globin gene cluster haplotypes were determined using the polymerase chain reaction restriction fragment-length polymorphism PCR-RFLP technique. For haplotype determination, 8 regions around and within the β-gene cluster were amplified by polymerase chain reaction. The 8 polymorphic restriction sites studied and the enzyme used in each case were: Hind II 5΄ to the ε gene, Xmn I 5΄ to the ᴳγ gene, Hind III within IVS-II of the ᴳγ and ᴬγ genes, Hind II 3΄ to ψβ gene, RsaI 5΄ to the β gene, AvaII for IVS-II of the β gene and HinfI 3΄ to the β gene. Genotyping of Thrombophilic mutations was carried out by (PCR-RFLP) using Mnl 1 and HindIII for FV-Leiden and prothrombin G20210A, respectively. One hundred seventy six (176) out of a total number of 234 chromosomes were βˢ, thirty-three (33) βThal, while twenty-five (25) had the wild type βᴬ gene. Four different typical haplotypes (Benin, Bantu, Cameroon, and Senegal) and four atypical ones (Bantu A2 (+----+++), Bantu A2c (+----++-), Bantu A2a (+----+-+) and Bantu A6a (--++-+-+)) were found in our patient population. The Benin haplotype was found to be the most prevalent in the study population in its heterozygous and homozygous states. This haplotype accounted for 82.4% of the homozygous form of the disease. The Bantu A2 atypical haplotype was the second most prevalent haplotype among our patients. The Bantu A2 haplotype accounted for 29.5% of the βᴬ haplotypes clarifying its high prevalence in our sample, and that it may be present a haplotype of normal population. Heterogeneity was observed in Hb F production in SS patients, ranging between (1.5-17%), whereas γᴳ ratio was homogeneous among all SS haplotypes with a normal amount of about (41%). Our results are in agreement with previous reports of the Benin haplotype origin in the Mediterranean. Thrombosis may play an important role in the pathophysiology of certain complications of sickle cell disease (SCD). Vascular complications such as ischemic stroke or deep vein thrombosis were diagnosed in seven patients. Age- and sexadjusted logistic regression analysis indicated a significant association between factor V Leiden mutation and sickle cell anemia with an odds ratios (OR) of 0.33 (95% confidence intervals [CI] of 0.12–0.94, P = 0.039) in SS patients. However, increased prevalence of the factor V Leiden in AS individuals and sickle/β-thalassemia patients was not statistically significant compared to controls. The prevalence of prothrombin G20210A mutation was not different between patients and controls, thereby giving no support to an association of single-point mutation with SCD. Although each of these mutations is relatively common in SCD, neither is independently associated with an increased risk of developing thrombophilic complications. This suggested a low impact of inherited hypercoagulability risk factors in the pathogenesis of SCD and/or its complications in Palestine.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Samarah, Fekri
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18742